Global Continuous Renal Replacement Therapy (CRRT) Market

1 INTRODUCTION OF GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) MARKET, BY PRODUCT
5.1 Dialysates and Replacement Fluids
5.2 Disposables
5.2.1 Eucalyptus
5.2.2 Citronella
5.2.3 Peppermint
5.3 Hemofilters
5.4 Bloodline Sets (Tubing Sets)
5.5 Other Disposables

6 ADOPTION OF CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT), BY REGION
6.1 Utilization of CRRT Procedures, By Region
6.2 Number of CRRT Patients, By Region

7 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

8 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies

9 COMPANY PROFILES
9.1 Baxter International Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments

9.2 Fresenius Medical Care AG & Co. KGaA
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments

9.3 Nikkiso Co., Ltd.
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments

9.4 Nxstage Medical, Inc.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments

9.5 B. Braun Melsungen AG
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments

9.6 Asahi Kasei Medical Co., Ltd.
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments

9.7 BeLLCo S.R.L.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments

9.8 Toray Medical Co., Ltd.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments

9.9 Infomed SA
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments

9.10 Medica S.P.A.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments

9.11 Medical Components, Inc.
9.11.1 Overview
9.11.2 Financial Performance
9.11.3 Product Outlook
9.11.4 Key Developments
9.12 Medites Pharma Spol. S.R.O.
9.12.1 Overview
9.12.2 Financial Performance
9.12.3 Product Outlook
9.12.4 Key Developments

9.13 Medtronic PLC
9.13.1 Overview
9.13.2 Financial Performance
9.13.3 Product Outlook
9.13.4 Key Developments

9.14 SWS Hemodialysis Care Co. Ltd.
9.14.1 Overview
9.14.2 Financial Performance
9.14.3 Product Outlook
9.14.4 Key Developments

9.15 Ningbo Tianyi Medical Appliance Co., Ltd.
9.15.1 Overview
9.15.2 Financial Performance
9.15.3 Product Outlook
9.15.4 Key Developments

10 Appendix
10.1 Related Reports